[1]
Saif, M.W. et al. 2014. Gemcitabine as Salvage Treatment in Patients with Poorly Differentiated Pancreatic Neuroendocrine Tumors: A Case Series. JOP. Journal of the Pancreas. 15, 1 (Jan. 2014), 38–41. DOI:https://doi.org/10.6092/1590-8577/1628.